InspireMD Inc.: InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today ...
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
(Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the fourth ...
Unlocking a common cause of ataxia: A step toward effective treatment
Cerebellar rhythm loss due to climbing fiber regression is a shared pathophysiology of motor deficits across cerebellar ...
AHA/ASA Journals1d
Sex Differences in Peripheral Vascular Disease: A Scientific Statement From the American Heart Association
Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been ...
Women with peripheral vascular disease often underdiagnosed and undertreated, highlighting need for more research
The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a ...
Physician's Weekly2d
Predictors and Outcomes of CHS in Carotid Revascularization
The following is a summary of "Cerebral Hyperperfusion Syndrome After Carotid Revascularization; Predictors and Complications," published in the March 2025 issue of the Annals of Vascular Surgery by ...